Patenting RNA Interference Technology

Law360, New York (May 10, 2005, 12:00 AM EDT) -- RNA interference technology initiates degradation of specific messenger RNA (mRNA) and prevents production of the protein which the mRNA encodes.  This technology shows promise both for treating disease and creating models of disease.  Now that the technology is generally known, can a company patent its own particular application?


As with all patent applications, the company must demonstrate that its RNA interference technology has utility, is adequately described in the specification of the patent application, and is both novel and nonobvious.  The United States Patent and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.